ABOUT OPHARMIC
Opharmic Technology (former Sonikure Technology) is a privately held medical technology company developing novel ocular drug delivery technology and devices. The company was founded in 2016 based on a patented ultrasound-mediated ocular drug delivery technology from the Hong Kong University of Science and Technology. With safety and feasibility well-demonstrated in pre-clinical studies, the technology non-invasively delivers large molecules to the posterior eye segment through the sclera. With the vision to replace invasive intravitreal injections, Opharmic is currently in preparation of two large-scale pre-clinical studies to streamline product development, and to validate additional technology applications.
Awards & Recognitions
Awards & Recognitions
- Deloitte Raising Star Award - 2017
- 45th International Exhibition of Invention Geneva - Prize of the State of Geneva; Prize of ULBS Romania - 2017
- IET Innovation Award - 2016 Winner (Healthcare)
- Google We Solve for X - Moonshot Project
- Kairos' Society K50 - 2015 Global Top 50 Startups
- Rice Business Plan Competition - 2015 Top 6 Semi-finalist
- TiE International Business Plan Competition - 2015 Winner (Hong Kong & Asia); Asia Rising Star Award
- The HKUST 4th Annual One Million Dollar Entrepreneurship Competition - 2nd Prize Winner
|
Publications & Presentations
      |
Vertical Divider
|
In the press
      |
Vertical Divider